Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (2,529)	$ (5,715)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	1,407	1,511
Stock-based compensation expense	6,509	7,530
Change in fair value of contingent consideration	(113)	(892)
Provision for bad debt	245	75
Unrealized foreign currency transaction losses	9	7
Changes in operating assets and liabilities:
Accounts receivable	(9,827)	(10,973)
Prepaid expenses and other current assets	1,709	(287)
Commissions receivable, current and non-current	595	(5,381)
Operating lease right-of-use assets	688	645
Other assets	36	(29)
Accounts payable	4	13,296
Accrued expenses and other current liabilities	852	(2,857)
Deferred revenue	80	(112)
Operating lease liabilities	(902)	(663)
Net cash used in operating activities	(1,237)	(3,845)
Cash flows from investing activities:
Acquisition of property and equipment, including costs capitalized for development of internal-use software	(1,007)	(681)
Net cash used in investing activities	(1,007)	(681)
Cash flows from financing activities:
Proceeds from exercise of stock options	287	558
Proceeds from private placement of common stock		15,000
Tax withholding payments related to net share settlement	(130)
Net cash provided by financing activities	157	15,558
Effect of exchange rate changes on cash, cash equivalents and restricted cash	5	(5)
Net increase (decrease) in cash, cash equivalents and restricted cash	(2,082)	11,027
Cash, cash equivalents and restricted cash at beginning of period	30,835	35,101
Cash, cash equivalents and restricted cash at end of period	28,753	46,128
Supplemental disclosure of noncash investing and financing information:
Acquisition of property and equipment included in accounts payable	$ 67	309
Operating lease liabilities arising from obtaining right-of-use assets		$ 567